Assoication of 3q21 syndrome with different RPN1/EVI1 fusion transcript in AML patients.
2002-01-01 Martinelli, G; Ottaviani, E; Isidori, A; Malagola, Michele; Buonamici, S; Testoni, N; Visani, G; Piccaluga, Pp; Rondoni, M; Tura, S; Baccarani, M.
Rapid detection of Flt3-ITD in acute myeloid leukemia patients by DF-HPLC
2002-01-01 Martinelli, G; Bianchini, M; Giannini, B; Grafone, T; Ottaviani, E; Amabile, M; Terragna, C; Soverini, S; Piccaluga, Pp; Isidori, A; Malagola, Michele; Rondoni, M; Buonamici, S; Baccarani, M.
Gentuzumab Ozogamycin (Mylotarg) for the treatment of relapsed/refractory acute myeloid leukemia. A single Centre experience.
2002-01-01 Piccaluga, Pp; Martinelli, G; Rondoni, M; Isidori, A; Malagola, Michele; Visani, G; Tura, S; Baccarani, M.
Efficacy of Glivec /STI571 in conjunction with alpha-interferon in a case of relapsed p190 BCR-ABL positive acute lymphoblastic leukemia.
2001-01-01 Visani, G; Isidori, A; Malagola, Michele; Alberti, D; Piccaluga, Pp; Martinelli, G; Amabile, M; Grafone, T; Delfini, C; Tura, S; Baccarani, M.
Pulsed ATRA as single therapy restores long term remission in molecular positive acute promyelocytic leukemia: real-time quantitation of minimal residual disease
2001-01-01 Visani, G; Malagola, Michele; Isidori, A; Piccaluga, Pp; Martinelli, G; Buonamici, S; Ottaviani, E; Grafone, T; Baccarani, M; Tura, S.
Antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia and myelodisplastic syndromes. Analysis of microvessels density and angiogenesis surrogate markers.
2002-01-01 Piccaluga, Pp; Visani, G; Pileri, Sa; Martinelli, G; Finelli, C; Ascani, S; Grafone, T; Isidori, A; Malagola, Michele; El cheick, J; Rondoni, M; Baccarani, M; Tura, S.
Chronic myeloid leukemia patients with complete karyotypic response to STI-571 (GLIVEC) therapy show rapid reduction of bcr-abl trancripts.
2002-01-01 Giannini, B; Martinelli, G; Rosti G., Amabile M; Trabacchi, E; Testoni, N; Buonamici, S; Ottaviani, E; Soverini, S; Bassi, S; Pane, F; Izzo, B; Saglio, G; Alberti, D; Baccarani, M; Isidori, A; Malagola, Michele; Piccaluga, Pp; Rondoni, M. on behalf of the ICSG C. M. L.
Real-time quantification of minimal residual disease in inv(16) positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state.
2002-01-01 Martinelli, G; Buonamici, S; Ottaviani, E; Testoni, N; Montefusco, V; Visani, G; Bonifazi, F; Amabile, M; Terragna, C; Ruggeri, D; Piccaluga, Pp; Isidori, A; Malagola, Michele; Baccarani, M; Tura, S.
Single Center experience of detection of minimal residual disease in patients with AML1/ETO associated acute myeloid leukemia by RT-PCR.
2001-01-01 Buonamici, S; Ottaviani, E; Testoni, N; Terragna, C; Amabile, M; Giannini, B; Soverini, S; Ruggeri, D; Luatti, S; Zardini, C; Visani, G; Piccaluga, Pp; Isidori, A; Malagola, Michele; Baccarani, M; Tura, S; Martinelli, G.
Efficacy of imatinib mesylate (STI 571) in conjunction with -interpheron: long term quantitative molecular remission in relapsed positive acute lymphoblastic leukemia.
2002-01-01 Visani, G; Isidori, A; Alberti, D; Malagola, Michele; Piccaluga, Pp; Martinelli, G; Amabile, M; Tura, S; Baccarani, M.
Association of 3q26 syndrome with different RPN1/EVI1 fusion transcripts in acute myeloblastic leukemia patients.
2002-01-01 Martinelli, G; Ottaviani, E; Isidori, A; Malagola, Michele; Buonamici, S; Testoni, N; Visnai, G; Piccaluga, P; Rondoni, M; Tura, S; Baccarani, M.
Pulsed ATRA as single therapy restores long term remission in PML-RARa positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease.
2001-01-01 Visani, G; Isidori, A; Malagola, Michele; Buonamici, S; Ottaviani, E; Martinelli, G.
Liposomal daunorubicin (DAUNOXOME) for treatment of relapsed meningeal acute myeloid leukemia.
2001-01-01 Piccaluga, Pp; Visani, G; Isidori, A; Malagola, Michele; Pileri, Sa; Baccarani, M; Tura, S.
Rare CBFbeta-MYH11 fusion transcripts in patients with acute myeloid leukemia associated with inversion of chromosome 16.
2001-01-01 Martinelli, G; Buonamici, S; Ottaviani, E; Testoni, N; Terragna, C; Amabile, M; Giannini, B; Soverini, S; Zardini, C; Visani, G; Isidori, A; Malagola, Michele; Ruggeri, D; Piccaluga, Pp; Baccarani, M; Tura, S.
Efficacy of thalidomide in myelofibrosis with myeloid metaplasia.
2001-01-01 Piccaluga, Pp; Visani, G; Pileri, Sa; Finelli, C; Ascani, S; Isidori, A; Malagola, Michele; Grafone, T; Baccarani, M; Tura, S.
Quantitative Rt-PCR in P-190bcrABL+ acute lymphoblastic leukemia: alpha-interferon after autologous-SCT reduces minimal residual disease allowing long term remission
2001-01-01 Visani, G; Martinelli, G; Amabile, M; Isidori, A; Malagola, Michele; Piccaluga, Pp; Pane, F; Ottaviani, E; Cavo, M; Testoni, N; Tura, S.
Double reinforcement with fludarabine/high dose cytarabine enanches the impact of autologous stem cell transplantation in acute myeloid leukemia patients.
2001-01-01 Visani, G; Lemoli, Rm; Isidori, A; Piccaluga, Pp; Martinelli, G; Gugliotta, L; Bonini, A; Malagola, Michele; Motta, Mr; Rizzi, S; Castellani, S; Tura, S.
Antiangiogenic therapy with thalidomide improves anemia, thrombocytopenia, hyperleucocytosis, splenomegaly in idiopathic myelofibrosis.
2000-01-01 Piccaluga, Pp; Finelli, C; Ricci, P; Cavo, M; Pileri, Sa; Isidori, A; Malagola, Michele; Grafone, T; Tura, S; Visani, G.
No preferential sensitivity of t(8;21) acute myeloid leukemia cells to cytosine arabinoside in vitro
2000-01-01 Grafone, T; Visani, G; Piccaluga, Pp; Isidori, A; Tosi, P; Malagola, Michele; Ottaviani, E; Testoni, N; Tura, S.
Alpha-interferon as an alternative to allogeneic bone marrow transplantation in the treatment of positive adult acute lymphoblastic leukemia.
2000-01-01 Isidori, A; Visani, G; Martinelli, G; Piccaluga, Pp; Tosi, P; Amabile, M; Pastano, R; Malagola, Michele; Cavo, M; Tura, S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Assoication of 3q21 syndrome with different RPN1/EVI1 fusion transcript in AML patients. | 1-gen-2002 | Martinelli, G; Ottaviani, E; Isidori, A; Malagola, Michele; Buonamici, S; Testoni, N; Visani, G; Piccaluga, Pp; Rondoni, M; Tura, S; Baccarani, M. | |
| Rapid detection of Flt3-ITD in acute myeloid leukemia patients by DF-HPLC | 1-gen-2002 | Martinelli, G; Bianchini, M; Giannini, B; Grafone, T; Ottaviani, E; Amabile, M; Terragna, C; Soverini, S; Piccaluga, Pp; Isidori, A; Malagola, Michele; Rondoni, M; Buonamici, S; Baccarani, M. | |
| Gentuzumab Ozogamycin (Mylotarg) for the treatment of relapsed/refractory acute myeloid leukemia. A single Centre experience. | 1-gen-2002 | Piccaluga, Pp; Martinelli, G; Rondoni, M; Isidori, A; Malagola, Michele; Visani, G; Tura, S; Baccarani, M. | |
| Efficacy of Glivec /STI571 in conjunction with alpha-interferon in a case of relapsed p190 BCR-ABL positive acute lymphoblastic leukemia. | 1-gen-2001 | Visani, G; Isidori, A; Malagola, Michele; Alberti, D; Piccaluga, Pp; Martinelli, G; Amabile, M; Grafone, T; Delfini, C; Tura, S; Baccarani, M. | |
| Pulsed ATRA as single therapy restores long term remission in molecular positive acute promyelocytic leukemia: real-time quantitation of minimal residual disease | 1-gen-2001 | Visani, G; Malagola, Michele; Isidori, A; Piccaluga, Pp; Martinelli, G; Buonamici, S; Ottaviani, E; Grafone, T; Baccarani, M; Tura, S. | |
| Antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia and myelodisplastic syndromes. Analysis of microvessels density and angiogenesis surrogate markers. | 1-gen-2002 | Piccaluga, Pp; Visani, G; Pileri, Sa; Martinelli, G; Finelli, C; Ascani, S; Grafone, T; Isidori, A; Malagola, Michele; El cheick, J; Rondoni, M; Baccarani, M; Tura, S. | |
| Chronic myeloid leukemia patients with complete karyotypic response to STI-571 (GLIVEC) therapy show rapid reduction of bcr-abl trancripts. | 1-gen-2002 | Giannini, B; Martinelli, G; Rosti G., Amabile M; Trabacchi, E; Testoni, N; Buonamici, S; Ottaviani, E; Soverini, S; Bassi, S; Pane, F; Izzo, B; Saglio, G; Alberti, D; Baccarani, M; Isidori, A; Malagola, Michele; Piccaluga, Pp; Rondoni, M. on behalf of the ICSG C. M. L. | |
| Real-time quantification of minimal residual disease in inv(16) positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state. | 1-gen-2002 | Martinelli, G; Buonamici, S; Ottaviani, E; Testoni, N; Montefusco, V; Visani, G; Bonifazi, F; Amabile, M; Terragna, C; Ruggeri, D; Piccaluga, Pp; Isidori, A; Malagola, Michele; Baccarani, M; Tura, S. | |
| Single Center experience of detection of minimal residual disease in patients with AML1/ETO associated acute myeloid leukemia by RT-PCR. | 1-gen-2001 | Buonamici, S; Ottaviani, E; Testoni, N; Terragna, C; Amabile, M; Giannini, B; Soverini, S; Ruggeri, D; Luatti, S; Zardini, C; Visani, G; Piccaluga, Pp; Isidori, A; Malagola, Michele; Baccarani, M; Tura, S; Martinelli, G. | |
| Efficacy of imatinib mesylate (STI 571) in conjunction with -interpheron: long term quantitative molecular remission in relapsed positive acute lymphoblastic leukemia. | 1-gen-2002 | Visani, G; Isidori, A; Alberti, D; Malagola, Michele; Piccaluga, Pp; Martinelli, G; Amabile, M; Tura, S; Baccarani, M. | |
| Association of 3q26 syndrome with different RPN1/EVI1 fusion transcripts in acute myeloblastic leukemia patients. | 1-gen-2002 | Martinelli, G; Ottaviani, E; Isidori, A; Malagola, Michele; Buonamici, S; Testoni, N; Visnai, G; Piccaluga, P; Rondoni, M; Tura, S; Baccarani, M. | |
| Pulsed ATRA as single therapy restores long term remission in PML-RARa positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. | 1-gen-2001 | Visani, G; Isidori, A; Malagola, Michele; Buonamici, S; Ottaviani, E; Martinelli, G. | |
| Liposomal daunorubicin (DAUNOXOME) for treatment of relapsed meningeal acute myeloid leukemia. | 1-gen-2001 | Piccaluga, Pp; Visani, G; Isidori, A; Malagola, Michele; Pileri, Sa; Baccarani, M; Tura, S. | |
| Rare CBFbeta-MYH11 fusion transcripts in patients with acute myeloid leukemia associated with inversion of chromosome 16. | 1-gen-2001 | Martinelli, G; Buonamici, S; Ottaviani, E; Testoni, N; Terragna, C; Amabile, M; Giannini, B; Soverini, S; Zardini, C; Visani, G; Isidori, A; Malagola, Michele; Ruggeri, D; Piccaluga, Pp; Baccarani, M; Tura, S. | |
| Efficacy of thalidomide in myelofibrosis with myeloid metaplasia. | 1-gen-2001 | Piccaluga, Pp; Visani, G; Pileri, Sa; Finelli, C; Ascani, S; Isidori, A; Malagola, Michele; Grafone, T; Baccarani, M; Tura, S. | |
| Quantitative Rt-PCR in P-190bcrABL+ acute lymphoblastic leukemia: alpha-interferon after autologous-SCT reduces minimal residual disease allowing long term remission | 1-gen-2001 | Visani, G; Martinelli, G; Amabile, M; Isidori, A; Malagola, Michele; Piccaluga, Pp; Pane, F; Ottaviani, E; Cavo, M; Testoni, N; Tura, S. | |
| Double reinforcement with fludarabine/high dose cytarabine enanches the impact of autologous stem cell transplantation in acute myeloid leukemia patients. | 1-gen-2001 | Visani, G; Lemoli, Rm; Isidori, A; Piccaluga, Pp; Martinelli, G; Gugliotta, L; Bonini, A; Malagola, Michele; Motta, Mr; Rizzi, S; Castellani, S; Tura, S. | |
| Antiangiogenic therapy with thalidomide improves anemia, thrombocytopenia, hyperleucocytosis, splenomegaly in idiopathic myelofibrosis. | 1-gen-2000 | Piccaluga, Pp; Finelli, C; Ricci, P; Cavo, M; Pileri, Sa; Isidori, A; Malagola, Michele; Grafone, T; Tura, S; Visani, G. | |
| No preferential sensitivity of t(8;21) acute myeloid leukemia cells to cytosine arabinoside in vitro | 1-gen-2000 | Grafone, T; Visani, G; Piccaluga, Pp; Isidori, A; Tosi, P; Malagola, Michele; Ottaviani, E; Testoni, N; Tura, S. | |
| Alpha-interferon as an alternative to allogeneic bone marrow transplantation in the treatment of positive adult acute lymphoblastic leukemia. | 1-gen-2000 | Isidori, A; Visani, G; Martinelli, G; Piccaluga, Pp; Tosi, P; Amabile, M; Pastano, R; Malagola, Michele; Cavo, M; Tura, S. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 4 Contributo in Atti di Convegno ...2932
Data di pubblicazione
- In corso di stampa4
- 2020 - 2026293
- 2010 - 20191256
- 2000 - 2009925
- 1990 - 1999392
- 1980 - 198961
- 1979 - 19791
Editore
- Ferrata Storti Foundation51
- American Society of Hematology34
- -32
- AIAM - Associazione Italiana di A...25
- Società Italiana di Malattie Infe...19
- ND18
- Ferrata-Storti Foundation15
- Società Italiana di Igiene, Medic...14
- Nature Publishing Group13
- International Society of Travel M...11
Rivista
- HAEMATOLOGICA101
- BLOOD55
- BONE MARROW TRANSPLANTATION23
- JOURNAL OF HYPERTENSION14
- THE JOURNAL OF UROLOGY14
- GEOPHYSICAL RESEARCH ABSTRACTS12
- HAEMATOLOGICA11
- DENTAL MATERIALS10
- JOURNAL OF DENTAL RESEARCH10
- GIORNALE DI GERONTOLOGIA9
Serie
- PROCEEDINGS - ACADEMY OF MANAGEMENT4
- INSIGHTS1
- MATERIALS RESEARCH PROCEEDINGS1
- OPEN ACCESS SERIES IN INFORMATICS1
- PROCEEDINGS OF THE INTERNATIONAL ...1
- SCIENTIFIC RESEARCH ABSTRACTS1
Keyword
- DIALYSIS8
- Ionic liquids8
- CO2 hydrogenation7
- HCC7
- Soil hydrology5
- Soil proteomics5
- Agricultural water balance4
- Catalysis for sustainability4
- circular economy4
- Cupriavidus metallidurans4
Lingua
- eng1928
- ita686
- fre27
- spa1
Accesso al fulltext
- no fulltext2579
- open226
- restricted67
- reserved59
- partially open1